![]()
|
|
||||||||
(Received for publication, August
31, 1994; and in revised form, October 25, 1994) A Chinese hamster ovary cell subline (CHO/664) >1000-fold
resistant to the S-adenosylmethionine decarboxylase (AdoMetDC)
inhibitor, CGP-48664
(4-(aminoiminomethyl)-2,3-dihydro-1H-inden-1-one-diaminomethylenehydrazone),
has been developed and characterized. The cells were also
cross-resistant to the highly specific nucleoside analog inhibitor of
AdoMetDC, MDL-73811. These unique cells stably overexpress AdoMetDC due
to a 10-16-fold amplification of the AdoMetDC gene, which
resulted in a similar increase in AdoMetDC transcript levels. In the
presence of 100 µM CGP-48664, the CHO/664 cells displayed
AdoMetDC activities similar to the parental line. Following removal of
the inhibitor, AdoMetDC activity increased steadily over 20 days to
10-12 times that found in parental CHO cells. Decarboxylated (dc)
AdoMet pools accumulated rapidly from <5 pmol/10
Volume 270,
Number 5,
Issue of February 3, 1995 pp. 2124-2132
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
cells
to 1000-1500 pmol/10
cells at 3 days due to
diffusion away of intracellular inhibitor and to the depletion of
putrescine and spermidine as aminopropyl acceptors in dcAdoMet-mediated
synthase reactions. Polyamine pools shifted as putrescine, and
spermidine pools were processed forward to spermine. During the period
from 3 days to 20 days, dcAdoMet pools fell steadily and eventually
stabilized at 100-200 pmol/10
cells. Providing excess
putrescine at this time as an aminopropyl acceptor rapidly lowered
dcAdoMet pools and led to a near normalization of polyamine pools,
indicating that both dcAdoMet and putrescine are essential in
maintaining steady-state polyamine pool profiles. As with cell line
variants that overproduce ornithine decarboxylase, polyamine transport
was found to be increased in CHO/664 cells due to an apparent inability
of the system to down-regulate polyamine transport in response to
polyamine excess. Given the unique metabolic disturbances seen in these
cells, we anticipate that in addition to providing a useful system for
evaluating the specificity of newly developed AdoMetDC inhibitors, they
will undoubtedly prove valuable for investigating the various
regulatory interrelationships involved in polyamine homeostasis and
possibly other aspects of purine metabolism.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
D. L. Kramer, P. Diegelman, J. Jell, S. Vujcic, S. Merali, and C. W. Porter Polyamine Acetylation Modulates Polyamine Metabolic Flux, a Prelude to Broader Metabolic Consequences J. Biol. Chem., February 15, 2008; 283(7): 4241 - 4251. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jell, S. Merali, M. L. Hensen, R. Mazurchuk, J. A. Spernyak, P. Diegelman, N. D. Kisiel, C. Barrero, K. K. Deeb, L. Alhonen, et al. Genetically Altered Expression of Spermidine/Spermine N1-Acetyltransferase Affects Fat Metabolism in Mice via Acetyl-CoA J. Biol. Chem., March 16, 2007; 282(11): 8404 - 8413. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rodriguez-Caso, R. Montanez, M. Cascante, F. Sanchez-Jimenez, and M. A. Medina Mathematical Modeling of Polyamine Metabolism in Mammals J. Biol. Chem., August 4, 2006; 281(31): 21799 - 21812. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Tucker, J. T. Murphy, N. Kisiel, P. Diegelman, K. W. Barbour, C. Davis, M. Medda, L. Alhonen, J. Janne, D. L. Kramer, et al. Potent Modulation of Intestinal Tumorigenesis in Apcmin/+ Mice by the Polyamine Catabolic Enzyme Spermidine/Spermine N1-acetyltransferase Cancer Res., June 15, 2005; 65(12): 5390 - 5398. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kee, B. A. Foster, S. Merali, D. L. Kramer, M. L. Hensen, P. Diegelman, N. Kisiel, S. Vujcic, R. V. Mazurchuk, and C. W. Porter Activated Polyamine Catabolism Depletes Acetyl-CoA Pools and Suppresses Prostate Tumor Growth in TRAMP Mice J. Biol. Chem., September 17, 2004; 279(38): 40076 - 40083. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kee, S. Vujcic, S. Merali, P. Diegelman, N. Kisiel, C. T. Powell, D. L. Kramer, and C. W. Porter Metabolic and Antiproliferative Consequences of Activated Polyamine Catabolism in LNCaP Prostate Carcinoma Cells J. Biol. Chem., June 25, 2004; 279(26): 27050 - 27058. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pless, K. Belhadj, H. D. Menssen, W. Kern, B. Coiffier, J. Wolf, R. Herrmann, E. Thiel, D. Bootle, I. Sklenar, et al. Clinical Efficacy, Tolerability, and Safety of SAM486A, a Novel Polyamine Biosynthesis Inhibitor, in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma: Results from a Phase II Multicenter Study Clin. Cancer Res., February 15, 2004; 10(4): 1299 - 1305. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hanfrey, M. Franceschetti, M. J. Mayer, C. Illingworth, and A. J. Michael Abrogation of Upstream Open Reading Frame-mediated Translational Control of a Plant S-Adenosylmethionine Decarboxylase Results in Polyamine Disruption and Growth Perturbations J. Biol. Chem., November 8, 2002; 277(46): 44131 - 44139. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Siu, E. K. Rowinsky, L. A. Hammond, G. R. Weiss, M. Hidalgo, G. M. Clark, J. Moczygemba, L. Choi, R. Linnartz, N. C. Barbet, et al. A Phase I and Pharmacokinetic Study of SAM486A, a Novel Polyamine Biosynthesis Inhibitor, Administered on a Daily-times-five every-three-week Schedule in Patients with Advanced Solid Malignancies Clin. Cancer Res., July 1, 2002; 8(7): 2157 - 2166. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, D. L. Kramer, P. Diegelman, S. Vujcic, and C. W. Porter Apoptotic Signaling in Polyamine Analogue-treated SK-MEL-28 Human Melanoma Cells Cancer Res., September 1, 2001; 61(17): 6437 - 6444. [Abstract] [Full Text] [PDF] |
||||
![]() |
V.-P. Korhonen, K. Niiranen, M. Halmekytö, M. Pietilä, P. Diegelman, J. J. Parkkinen, T. Eloranta, C. W. Porter, L. Alhonen, and J. Jänne Spermine Deficiency Resulting from Targeted Disruption of the Spermine Synthase Gene in Embryonic Stem Cells Leads to Enhanced Sensitivity to Antiproliferative Drugs Mol. Pharmacol., February 1, 2001; 59(2): 231 - 238. [Abstract] [Full Text] |
||||
![]() |
H. Dai, D. L. Kramer, C. Yang, K. G. Murti, C. W. Porter, and J. L. Cleveland The Polyamine Oxidase Inhibitor MDL-72,527 Selectively Induces Apoptosis of Transformed Hematopoietic Cells through Lysosomotropic Effects Cancer Res., October 1, 1999; 59(19): 4944 - 4954. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Arbeit, R. R. Riley, B. Huey, C. Porter, G. Kelloff, R. Lubet, J. M. Ward, and D. Pinkel Difluoromethylornithine Chemoprevention of Epidermal Carcinogenesis in K14-HPV16 Transgenic Mice Cancer Res., August 1, 1999; 59(15): 3610 - 3620. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Alhonen, M. Pietilä, M. Halmekytö, D. L. Kramer, J. Jänne, and C. W. Porter Transgenic Mice with Activated Polyamine Catabolism due to Overexpression of Spermidine/Spermine N1-Acetyltransferase Show Enhanced Sensitivity to the Polyamine Analog, N1,N11-Diethylnorspermine Mol. Pharmacol., April 1, 1999; 55(4): 693 - 698. [Abstract] [Full Text] |
||||
![]() |
D. L. Kramer, S. Vujcic, P. Diegelman, J. Alderfer, J. T. Miller, J. D. Black, R. J. Bergeron, and C. W. Porter Polyamine Analogue Induction of the p53-p21WAF1/CIP1-Rb Pathway and G1 Arrest in Human Melanoma Cells Cancer Res., March 1, 1999; 59(6): 1278 - 1286. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Alhonen, A. Karppinen, M. Uusi-Oukari, S. Vujcic, V.-P. Korhonen, M. Halmekyto, D. L. Kramer, R. Hines, J. Janne, and C. W. Porter Correlation of Polyamine and Growth Responses to N1,N11-Diethylnorspermine in Primary Fetal Fibroblasts Derived from Transgenic Mice Overexpressing Spermidine/Spermine N1-Acetyltransferase J. Biol. Chem., January 23, 1998; 273(4): 1964 - 1969. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pietila, L. Alhonen, M. Halmekyto, P. Kanter, J. Janne, and C. W. Porter Activation of Polyamine Catabolism Profoundly Alters Tissue Polyamine Pools and Affects Hair Growth and Female Fertility in Transgenic Mice Overexpressing Spermidine/Spermine N1-Acetyltransferase J. Biol. Chem., July 25, 1997; 272(30): 18746 - 18751. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Frostesjo, I. Holm, B. Grahn, A. W. Page, T. H. Bestor, and O. Heby Interference with DNA Methyltransferase Activity and Genome Methylation during F9 Teratocarcinoma Stem Cell Differentiation Induced by Polyamine Depletion J. Biol. Chem., February 14, 1997; 272(7): 4359 - 4366. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. McCloskey and A. E. Pegg Altered Spermidine/Spermine N1-Acetyltransferase Activity as a Mechanism of Cellular Resistance to Bis(ethyl)polyamine Analogues J. Biol. Chem., September 8, 2000; 275(37): 28708 - 28714. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |